{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T02:06:40Z","timestamp":1788919600635,"version":"build-2803163510"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:00:00Z","timestamp":1788912000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:00:00Z","timestamp":1788912000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"DOI":"10.1007\/s00198-026-08148-6","type":"journal-article","created":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T01:27:02Z","timestamp":1788917222000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effects of romosozumab on the peripheral and axial skeleton in postmenopausal women at high fracture risk: real-world evidence from DXA and HR-pQCT data"],"prefix":"10.1007","author":[{"given":"M. S. A. M.","family":"Bevers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. E.","family":"Wyers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"van Rietbergen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3984-2232","authenticated-orcid":false,"given":"J. P.","family":"van den Bergh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,9]]},"reference":[{"key":"8148_CR1","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S127568","author":"SY Lim","year":"2017","unstructured":"Lim SY, Bolster MB (2017) Profile of romosozumab and its potential in the management of osteoporosis. Drug Des Devel Ther. https:\/\/doi.org\/10.2147\/DDDT.S127568","journal-title":"Drug Des Devel Ther"},{"issue":"1","key":"8148_CR2","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1080\/14712598.2022.2152320","volume":"23","author":"P Geusens","year":"2023","unstructured":"Geusens P, Appelman-Dijkstra N, Lems W, Van den Bergh J (2023) Romosozumab for the treatment of postmenopausal women at high risk of fracture. Expert Opin Biol Ther 23(1):11\u201319","journal-title":"Expert Opin Biol Ther"},{"key":"8148_CR3","doi-asserted-by":"crossref","unstructured":"M\u00e4kinen VN, S\u00f8lling AS, McClung M, Langdahl BL (2024) Romosozumab for the treatment of osteoporosis\u2013a systematic review. J Endocrinol Investig 48(3):547\u2013572","DOI":"10.1007\/s40618-024-02469-1"},{"issue":"1","key":"8148_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00198-021-06095-y","volume":"33","author":"S Singh","year":"2022","unstructured":"Singh S, Dutta S, Khasbage S et al (2022) A systematic review and meta-analysis of efficacy and safety of romosozumab in postmenopausal osteoporosis. Osteoporos Int 33(1):1\u201312","journal-title":"Osteoporos Int"},{"issue":"5","key":"8148_CR5","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1007\/s00774-024-01531-5","volume":"42","author":"T Kobayashi","year":"2024","unstructured":"Kobayashi T, Hara M, Shimanoe C et al (2024) Efficacy and safety of romosozumab: a meta-analysis of placebo-controlled trials. J Bone Miner Metab 42(5):492\u2013502","journal-title":"J Bone Miner Metab"},{"issue":"6","key":"8148_CR6","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1007\/s00198-021-06174-0","volume":"33","author":"F Cosman","year":"2022","unstructured":"Cosman F, Kendler DL, Langdahl BL et al (2022) Romosozumab and antiresorptive treatment: the importance of treatment sequence. Osteoporos Int 33(6):1243\u20131256","journal-title":"Osteoporos Int"},{"issue":"5","key":"8148_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2021.105219","volume":"88","author":"K Ebina","year":"2021","unstructured":"Ebina K, Tsuboi H, Nagayama Y et al (2021) Effects of prior osteoporosis treatment on 12-month treatment response of romosozumab in patients with postmenopausal osteoporosis. Joint Bone Spine 88(5):105219","journal-title":"Joint Bone Spine"},{"issue":"9","key":"8148_CR8","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1007\/s00198-024-07155-9","volume":"35","author":"J Everts-Graber","year":"2024","unstructured":"Everts-Graber J, Wenger M, Oser S et al (2024) The effect of romosozumab on bone mineral density depending on prior treatment: a prospective, multicentre cohort study in Switzerland. Osteoporos Int 35(9):1605\u20131613","journal-title":"Osteoporos Int"},{"issue":"2","key":"8148_CR9","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1002\/jcph.239","volume":"54","author":"D Padhi","year":"2014","unstructured":"Padhi D, Allison M, Kivitz AJ et al (2014) Multiple doses of sclerostin antibody romosozumab in healthy men and postmenopausal women with low bone mass: a randomized, double\u2010blind, placebo-controlled study. J Clin Pharmacol 54(2):168\u2013178","journal-title":"J Clin Pharmacol"},{"issue":"5","key":"8148_CR10","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1056\/NEJMoa1305224","volume":"370","author":"MR McClung","year":"2014","unstructured":"McClung MR, Grauer A, Boonen S et al (2014) Romosozumab in postmenopausal women with low bone mineral density. N Engl J Med 370(5):412\u2013420","journal-title":"N Engl J Med"},{"issue":"9","key":"8148_CR11","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1002\/jbmr.3735","volume":"34","author":"P Chavassieux","year":"2019","unstructured":"Chavassieux P, Chapurlat R, Portero-Muzy N et al (2019) Bone-forming and antiresorptive effects of romosozumab in postmenopausal women with osteoporosis: bone histomorphometry and microcomputed tomography analysis after 2 and 12 months of treatment. J Bone Miner Res 34(9):1597\u20131608","journal-title":"J Bone Miner Res"},{"issue":"1","key":"8148_CR12","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1002\/jbmr.4457","volume":"37","author":"EF Eriksen","year":"2020","unstructured":"Eriksen EF, Chapurlat R, Boyce R et al (2020) Modeling\u2010based bone formation after 2 months of romosozumab treatment: results from the FRAME clinical trial. J Bone Miner Res 37(1):36\u201340","journal-title":"J Bone Miner Res"},{"key":"8148_CR13","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.bone.2015.07.036","volume":"81","author":"C Graeff","year":"2015","unstructured":"Graeff C, Campbell GM, Pe\u00f1a J et al (2015) Administration of romosozumab improves vertebral trabecular and cortical bone as assessed with quantitative computed tomography and finite element analysis. Bone 81:364\u2013369","journal-title":"Bone"},{"issue":"1","key":"8148_CR14","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1002\/jbmr.2932","volume":"32","author":"HK Genant","year":"2017","unstructured":"Genant HK, Engelke K, Bolognese MA et al (2017) Effects of romosozumab compared with teriparatide on bone density and mass at the spine and hip in postmenopausal women with low bone mass. J Bone Miner Res 32(1):181\u2013187","journal-title":"J Bone Miner Res"},{"issue":"9","key":"8148_CR15","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.1002\/jbmr.3176","volume":"32","author":"TM Keaveny","year":"2017","unstructured":"Keaveny TM, Crittenden DB, Bolognese MA et al (2017) Greater gains in spine and hip strength for romosozumab compared with teriparatide in postmenopausal women with low bone mass. J Bone Miner Res 32(9):1956\u20131962","journal-title":"J Bone Miner Res"},{"issue":"2","key":"8148_CR16","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1002\/jbmr.4465","volume":"37","author":"KE Poole","year":"2020","unstructured":"Poole KE, Treece GM, Pearson RA et al (2020) Romosozumab enhances vertebral bone structure in women with low bone density. J Bone Miner Res 37(2):256\u2013264","journal-title":"J Bone Miner Res"},{"issue":"11","key":"8148_CR17","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.1002\/jbmr.4409","volume":"36","author":"JP Brown","year":"2021","unstructured":"Brown JP, Engelke K, Keaveny TM et al (2021) Romosozumab improves lumbar spine bone mass and bone strength parameters relative to alendronate in postmenopausal women: results from the Active\u2010Controlled Fracture Study in Postmenopausal Women With Osteoporosis at High Risk (ARCH) trial. J Bone Miner Res 36(11):2139\u20132152","journal-title":"J Bone Miner Res"},{"issue":"12","key":"8148_CR18","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1007\/s00198-023-06889-2","volume":"34","author":"N Hong","year":"2023","unstructured":"Hong N, Shin S, Lee S, Rhee Y (2023) Romosozumab is associated with greater trabecular bone score improvement compared to denosumab in postmenopausal osteoporosis. Osteoporos Int 34(12):2059\u20132067","journal-title":"Osteoporos Int"},{"issue":"2","key":"8148_CR19","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1093\/jbmr\/zjae194","volume":"40","author":"MR McClung","year":"2025","unstructured":"McClung MR, Betah D, Leder BZ et al (2025) Romosozumab improves microarchitecture as assessed by tissue thickness\u2013adjusted trabecular bone score in postmenopausal women with osteoporosis. J Bone Miner Res 40(2):193\u2013200","journal-title":"J Bone Miner Res"},{"key":"8148_CR20","doi-asserted-by":"crossref","unstructured":"Lespessailles E, Hambli R, Ferrari S (2016) Osteoporosis drug effects on cortical and trabecular bone microstructure: a review of HR-pQCT analyses. BoneKey Rep 5:836","DOI":"10.1038\/bonekey.2016.59"},{"issue":"8","key":"8148_CR21","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1007\/s00198-021-05999-z","volume":"32","author":"JP Van den Bergh","year":"2021","unstructured":"Van den Bergh JP, Szulc P, Cheung AM, Bouxsein M, Engelke K, Chapurla R (2021) The clinical application of high-resolution peripheral computed tomography (HR-pQCT) in adults: state of the art and future directions. Osteoporos Int 32(8):1465\u20131485","journal-title":"Osteoporos Int"},{"issue":"12","key":"8148_CR22","doi-asserted-by":"publisher","first-page":"2558","DOI":"10.1002\/jbmr.157","volume":"25","author":"AJ Burghardt","year":"2010","unstructured":"Burghardt AJ, Kazakia GJ, Sode M, de Papp AE, Link TM, Majumdar S (2010) A longitudinal HR\u2010pQCT study of alendronate treatment in postmenopausal women with low bone density: relations among density, cortical and trabecular microarchitecture, biomechanics, and bone turnover. J Bone Miner Res 25(12):2558\u20132571","journal-title":"J Bone Miner Res"},{"issue":"4","key":"8148_CR23","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1002\/jbmr.3036","volume":"32","author":"MS Ominsky","year":"2017","unstructured":"Ominsky MS, Boyd SK, Varela A et al (2017) Romosozumab improves bone mass and strength while maintaining bone quality in ovariectomized cynomolgus monkeys. J Bone Miner Res 32(4):788\u2013801","journal-title":"J Bone Miner Res"},{"key":"8148_CR24","doi-asserted-by":"crossref","unstructured":"Zanchetta MB, Pernas MG, Jerkovich F, et al (2026) Assessing cortical bone changes with romosozumab after one year: insights from an exploratory HR-pQCT study. Bone Reports 101902","DOI":"10.1016\/j.bonr.2026.101902"},{"issue":"1","key":"8148_CR25","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s11657-024-01378-3","volume":"19","author":"JP Van den Bergh","year":"2024","unstructured":"Van den Bergh JP, Geusens P, Appelman-Dijkstra NM et al (2024) The Dutch multidisciplinary guideline osteoporosis and fracture prevention, taking a local guideline to the international arena. Arch Osteoporos 19(1):23","journal-title":"Arch Osteoporos"},{"key":"8148_CR26","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1002\/jbmr.5650080915","volume":"8","author":"HK Genant","year":"1993","unstructured":"Genant HK, Wu CY, Van Kuijk C, Nevitt MC (1993) Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res 8:1137\u20131148","journal-title":"J Bone Miner Res"},{"issue":"9321","key":"8148_CR27","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1016\/S0140-6736(02)08761-5","volume":"359","author":"JA Kanis","year":"2002","unstructured":"Kanis JA (2002) Diagnosis of osteoporosis and assessment of fracture risk. Lancet 359(9321):1929\u20131936","journal-title":"Lancet"},{"key":"8148_CR28","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1007\/s00198-020-05438-5","volume":"31","author":"DE Whittier","year":"2020","unstructured":"Whittier DE, Boyd SK, Burghardt AJ et al (2020) Guidelines for the assessment of bone density and microarchitecture in vivo using high-resolution peripheral quantitative computed tomography. Osteoporos Int 31:1607\u20131627","journal-title":"Osteoporos Int"},{"issue":"1","key":"8148_CR29","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.bone.2011.10.003","volume":"50","author":"JB Pialat","year":"2012","unstructured":"Pialat JB, Burghardt AJ, Sode M, Link TM, Majumdar S (2012) Visual grading of motion induced image degradation in high resolution peripheral computed tomography: impact of image quality on measures of bone density and micro-architecture. Bone 50(1):111\u2013118","journal-title":"Bone"},{"issue":"3","key":"8148_CR30","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1007\/s00223-018-0416-2","volume":"103","author":"EA De Waard","year":"2018","unstructured":"De Waard EA, Sarodnik C, Pennings A et al (2018) Reliability of HR-pQCT derived cortical bone structural parameters when using uncorrected instead of corrected automatically generated endo-cortical contours in a cross-sectional study: the Maastricht study. Calcif Tissue Int 103(3):252\u2013265","journal-title":"Calcif Tissue Int"},{"issue":"6","key":"8148_CR31","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/S8756-3282(02)00736-6","volume":"30","author":"W Pistoia","year":"2002","unstructured":"Pistoia W, Van Rietbergen B, Lochm\u00fcller EM, Lill CA, Eckstein F, R\u00fcegsegger P (2002) Estimation of distal radius failure load with micro-finite element analysis models based on three-dimensional peripheral quantitative computed tomography images. Bone 30(6):842\u2013848","journal-title":"Bone"},{"key":"8148_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2023.116859","volume":"175","author":"MSAM Bevers","year":"2023","unstructured":"Bevers MSAM, Heyer FL, Wyers CE et al (2023) The contribution of lower-mineralized tissue to the healing of distal radius fractures assessed using HR-pQCT. Bone 175:116859","journal-title":"Bone"},{"issue":"7","key":"8148_CR33","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1002\/jbmr.4285","volume":"36","author":"B van Rietbergen","year":"2020","unstructured":"van Rietbergen B, Biver E, Chevalley T, Ito K, Chapurlat R, Ferrari S (2020) A novel HR-pQCT image registration approach reveals sex-specific changes in cortical bone retraction with aging. J Bone Miner Res 36(7):1351\u20131363","journal-title":"J Bone Miner Res"},{"issue":"1","key":"8148_CR34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0191369","volume":"13","author":"P Christen","year":"2018","unstructured":"Christen P, Boutroy S, Ellouz R, Chapurlat R, van Rietbergen B (2018) Least-detectable and age-related local in vivo bone remodelling assessed by time-lapse HR-pQCT. PLoS ONE 13(1):e0191369","journal-title":"PLoS ONE"},{"issue":"7","key":"8148_CR35","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2021-058983","volume":"12","author":"L Vranken","year":"2022","unstructured":"Vranken L, Wyers CE, Van der Velde RY et al (2022) Association between incident falls and subsequent fractures in patients attending the fracture liaison service after an index fracture: a 3-year prospective observational cohort study. BMJ Open 12(7):e058983","journal-title":"BMJ Open"},{"issue":"9","key":"8148_CR36","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1007\/s00198-019-05081-9","volume":"30","author":"L Vranken","year":"2019","unstructured":"Vranken L, Wyers CE, van Rietbergen B et al (2019) The association between prevalent vertebral fractures and bone quality of the distal radius and distal tibia as measured with HR-pQCT in postmenopausal women with a recent non-vertebral fracture at the Fracture Liaison Service. Osteoporos Int 30(9):1789\u20131797","journal-title":"Osteoporos Int"},{"key":"8148_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2024.117066","volume":"182","author":"MR Schene","year":"2024","unstructured":"Schene MR, Bevers MSAM, Van der Vijgh WJF et al (2024) PPI use is not associated with bone microarchitecture and strength assessed with HR-pQCT after three-years follow-up in patients visiting the fracture liaison service. Bone 182:117066","journal-title":"Bone"},{"key":"8148_CR38","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1007\/s001980050008","volume":"11","author":"R Patel","year":"2000","unstructured":"Patel R, Blake GM, Rymer J, Fogelman I (2000) Long-term precision of DXA scanning assessed over seven years in forty postmenopausal women. Osteoporos Int 11:68\u201375","journal-title":"Osteoporos Int"},{"key":"8148_CR39","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1007\/s00198-007-0382-4","volume":"18","author":"P Tothill","year":"2007","unstructured":"Tothill P, Hannan WJ (2007) Precision and accuracy of measuring changes in bone mineral density by dual-energy X-ray absorptiometry. Osteoporos Int 18:1515\u20131523","journal-title":"Osteoporos Int"},{"issue":"2","key":"8148_CR40","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.jocd.2017.01.006","volume":"21","author":"K Chiba","year":"2018","unstructured":"Chiba K, Okazaki N, Kurogi A et al (2018) Precision of second-generation high-resolution peripheral quantitative computed tomography: intra-and intertester reproducibilities and factors involved in the reproducibility of cortical porosity. J Clin Densitom 21(2):295\u2013302","journal-title":"J Clin Densitom"},{"key":"8148_CR41","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1007\/s00198-020-05449-2","volume":"31","author":"TD Kemp","year":"2020","unstructured":"Kemp TD, de Bakker CMJ, Gabel L et al (2020) Longitudinal bone microarchitectural changes are best detected using image registration. Osteoporos Int 31:1995\u20132005","journal-title":"Osteoporos Int"},{"issue":"1","key":"8148_CR42","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B Stat Methodol 57(1):289\u2013300","journal-title":"J R Stat Soc Ser B Stat Methodol"},{"issue":"16","key":"8148_CR43","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1056\/NEJMoa1607948","volume":"375","author":"F Cosman","year":"2016","unstructured":"Cosman F, Crittenden DB, Adachi JD et al (2016) Romosozumab treatment in postmenopausal women with osteoporosis. N Engl J Med 375(16):1532\u20131543","journal-title":"N Engl J Med"},{"issue":"15","key":"8148_CR44","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1056\/NEJMoa1708322","volume":"377","author":"KG Saag","year":"2017","unstructured":"Saag KG, Petersen J, Brandi ML et al (2017) Romosozumab or alendronate for fracture prevention in women with osteoporosis. N Engl J Med 377(15):1417\u20131427","journal-title":"N Engl J Med"},{"issue":"10","key":"8148_CR45","doi-asserted-by":"publisher","DOI":"10.1093\/jbmrpl\/ziaf119","volume":"9","author":"T Damm","year":"2025","unstructured":"Damm T, Libanati C, Pe\u00f1a J et al (2025) Romosozumab significantly improves vertebral cortical bone mass and structure compared with teriparatide, whereas both treatments increase vertebral trabecular bone mass similarly: high-resolution quantitative computed tomography analyses of randomized controlled trial results in postmenopausal women with low bone mineral density. JBMR Plus 9(10):ziaf119","journal-title":"JBMR Plus"},{"key":"8148_CR46","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1007\/s00198-018-4445-5","volume":"29","author":"MA Paggiosi","year":"2018","unstructured":"Paggiosi MA, Yang L, Blackwell D et al (2018) Teriparatide treatment exerts differential effects on the central and peripheral skeleton: results from the MOAT study. Osteoporos Int 29:1367\u20131378","journal-title":"Osteoporos Int"},{"key":"8148_CR47","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/s00198-010-1226-1","volume":"22","author":"HM Macdonald","year":"2011","unstructured":"Macdonald HM, Nishiyama KK, Hanley DA, Boyd SK (2011) Changes in trabecular and cortical bone microarchitecture at peripheral sites associated with 18 months of teriparatide therapy in postmenopausal women with osteoporosis. Osteoporos Int 22:357\u2013362","journal-title":"Osteoporos Int"},{"issue":"4","key":"8148_CR48","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1002\/jbmr.1784","volume":"28","author":"S Hansen","year":"2013","unstructured":"Hansen S, Hauge EM, Beck Jensen JE, Brixen K (2013) Differing effects of PTH 1\u201334, PTH 1\u201384, and zoledronic acid on bone microarchitecture and estimated strength in postmenopausal women with osteoporosis: an 18\u2010month open\u2010labeled observational study using HR\u2010pQCT. J Bone Miner Res 28(4):736\u2013745","journal-title":"J Bone Miner Res"},{"issue":"10","key":"8148_CR49","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.1002\/jbmr.111","volume":"25","author":"XS Liu","year":"2010","unstructured":"Liu XS, Cohen A, Shane E et al (2010) Bone density, geometry, microstructure, and stiffness: relationships between peripheral and central skeletal sites assessed by DXA, HR-pQCT, and QCT in premenopausal women. J Bone Miner Res 25(10):2229\u20132238","journal-title":"J Bone Miner Res"},{"key":"8148_CR50","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1007\/s00774-015-0708-9","volume":"34","author":"AK Amstrup","year":"2016","unstructured":"Amstrup AK, Jakobsen NFB, Moser E, Sikjaer T, Mosekilde L, Rejnmark L (2016) Association between bone indices assessed by DXA, HR-pQCT and QCT scans in post-menopausal women. J Bone Miner Metab 34:638\u2013645","journal-title":"J Bone Miner Metab"},{"key":"8148_CR51","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.bone.2014.03.043","volume":"64","author":"JJ de Jong","year":"2014","unstructured":"de Jong JJ, Willems PC, Arts JJ et al (2014) Assessment of the healing process in distal radius fractures by high resolution peripheral quantitative computed tomography. Bone 64:65\u201374","journal-title":"Bone"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-026-08148-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00198-026-08148-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-026-08148-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T01:27:04Z","timestamp":1788917224000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00198-026-08148-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,9]]},"references-count":51,"alternative-id":["8148"],"URL":"https:\/\/doi.org\/10.1007\/s00198-026-08148-6","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,9]]},"assertion":[{"value":"17 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"None of the individuals included in this study had actively opted out for use of their medical data for research.","order":1,"name":"Ethics","label":"Patient consent","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"B. van Rietbergen is a consultant for SCANCO Medical AG and Amolyt pharma. JvdB is a consultant for Amgen, UCB, and Porous GmbH and received lecture fees from Amgen and UCB. All other authors declare no conflicts of interest.","order":2,"name":"Ethics","label":"Conflicts of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}